MSC Therapy Shows Promise Despite Mixed Clinical Results
Review reveals safety of mesenchymal stem cell therapy but highlights efficacy challenges in clinical trials.
20 articles
Review reveals safety of mesenchymal stem cell therapy but highlights efficacy challenges in clinical trials.
Comprehensive review reveals how MSCs repair tissues and modulate immunity across multiple diseases, offering new therapeutic pathways.
Une revue exhaustive de 2025 révèle comment les CSM réparent les foies endommagés grâce à l'immunomodulation, à l'action anti-fibrotique et à la signalisation régénératrice.
Une nouvelle revue consolide les avancées en biologie des CSM, les approbations cliniques, et les obstacles à la standardisation qui freinent encore un succès thérapeutique plus large.
Une revue de 2025 cartographie les données précliniques et cliniques relatives à la thérapie par CSM dans la maladie d'Alzheimer, en détaillant les mécanismes, les limites et les perspectives futures.
A comprehensive 2025 review maps the mechanisms, sources, and clinical applications of mesenchymal stem cells and their derived exosomes across cardiovascular, neurological, autoimmune, and musculoskeletal diseases.
Les essais de phase Ia/Ib d'escalade de doses révèlent que la thérapie par cellules souches mésenchymateuses (MSC) est sûre dans la cirrhose hépatique décompensée, des doses plus élevées produisant des effets de rééquilibrage immunitaire plus marqués.
65-patient trial tested bone marrow stem cells injected directly into damaged heart muscle to restore function in chronic heart failure.
La combinaison de la transplantation de cellules souches mésenchymateuses avec l'exercice physique pourrait permettre de surmonter les principales limites d'une thérapie en monothérapie contre la sarcopénie.
Scientists created modified stem cells that home to bone marrow, delivering targeted immune therapies while avoiding tumors entirely.
Researchers compared stem cells from arthritis patients versus healthy donors to assess regenerative therapy potential.
Adipose-derived stem cells combined with platelet-rich plasma evaluated for treating moderate to severe knee osteoarthritis over 2 years.
32-person trial compared bone marrow stem cells, platelet therapy, and hyaluronic acid for knee arthritis treatment over one year.
Tiny particles from stem cells could deliver therapeutic benefits without the risks of traditional cell-based treatments.
Combining nanoparticles with mesenchymal stem cells could finally overcome the poor survival and differentiation that limits cartilage regeneration.
Small trial tests autologous stem cells to regenerate damaged knee cartilage in osteoarthritis patients with promising safety profile.
Scientists explore safer alternatives to stem cell transplants using cellular secretions that may offer similar benefits.
Mesoblast licenses CAR technology to make its stem cell therapies smarter at finding inflamed tissue, targeting IBD and autoimmune disease.
A comprehensive review maps how mesenchymal stem cells and their exosomes combat Alzheimer's, atherosclerosis, osteoporosis, and ovarian failure.
Analysis of 449 clinical trials reveals mesenchymal stem cells are leading treatment for osteoarthritis and rheumatoid arthritis worldwide.